Knappskog and colleagues found that MDM2 T309 G SNP affected cancer risk through modulation of Sp1 transcription factor binding.20 Other researchers reported that key SNP changes of MDM2 may have a large impact on the activity of p53‐dependent tumor suppression. The gene discussed is TP53; the disease is neoplasm.